Supporting U.S. troops through great leadership

Prime Therapeutics employee recently honored with the Patriotic Employer award.

June 25, 2021
Anne Mack, senior director, network compliance for Prime Therapeutics (Prime), was a key supporter in helping Marcus Caruso complete his obligations as an active member of the military.

Anne MackThis backing inspired Caruso, director, shared services for Prime, to nominate Mack for the Employer Support of the Guard and Reserve’s (ESGR) Patriotic Employer award. The U.S. Department of Defense award “reflects the efforts made to support citizen warriors through a wide-range of measures including flexible schedules, time off prior to and after deployment, caring for families and granting leaves of absence.”

When Caruso was called to complete a six-week military training in Missouri, Mack quickly jumped in to provide her full support. Mack seamlessly handled her day-to-day responsibilities while also making sure Caruso’s team had what they needed to be successful while he was at training.

“I have a large team with a wide array of responsibilities,” said Caruso. “I expected to be contacted with questions while I was at training, but Anne had it all covered. I didn’t ever feel I was missing out or falling behind while I was away. It felt good to have her support.”

Receiving this award means a lot to Mack, and she says she’s learned a lot from Caruso. “It’s been a great experience working with Marcus,” Mack said. “I enjoy learning how things work in the military and hearing some of the analogies he has for how things translate from the military to civilian life.”

Mack adds, “Marcus explained that not all employers are supportive of employees serving in the military and that surprised me.”

Caruso will officially present this award to Mack in person later this summer.

If you are a Guard or Reserve member or spouse and know someone that should be nominated for this award, visit the ESGR website.

Related news

Stories

July 22, 2024

Introducing the latest issue of our medical and pharmacy benefit management report

The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care

Stories

July 18, 2024

Specialty drug trend forecasted to drop for employer groups, clinical experts say

Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend

Stories

July 16, 2024

Prime/Magellan Rx earns top score on the Disability Equality Index

For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion